DC Circ. Won't Revisit Revival Of Pharma Terror-Funding Case
The full D.C. Circuit will not review a panel's revival of a lawsuit accusing AstraZeneca Pharmaceuticals LP, Pfizer Inc. and several other pharmaceutical companies of helping finance terror attacks that injured...To view the full article, register now.
Already a subscriber? Click here to view full article